Eli Kotler, MD, is a consultant psychiatrist, holds an academic position at Monash University through the Alfred Psychiatry Research Centre, and is the medical director of Malvern Private Hospital, the first addiction hospital in Australia. Through involvement with Monash University, Eli oversees the addiction rotation for medical students. He is a member of the Australasian Professional Society on Alcohol and other Drugs (APSAD).
Clinically, Eli is interested in the deep connections between trauma and addiction and works within a neuro-psychoanalytic framework. Eli has overseen the development of a clinical program for addictions focused on trauma, particularly developmental trauma. This has led to an interest in psychedelic-assisted trauma therapy. He has recently been appointed as the Principal Investigator to lead Emyria’s upcoming MDMA-assisted therapy trial for treatment-resistant PTSD. Eli also worked for many years researching neurodegenerative diseases and was the Principal Investigator on numerous trials for novel therapeutics.
Eli graduated from the first intake of the Certificate in Psychedelic-Assisted Therapies (CPAT) in June 2021 and is currently part of the teaching faculty on the CPAT course run by the charity Mind Medicine Australia. Eli is a Director at Mind Medicine Australia, and the founding member of the Melbourne Neuropsychoanalytic Group.
Eli will present for Delphi for the first time in 2022.
Photo credit: Dwight Carter
– Mary Angelou